Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (191-200 of 397) with videos related to

Pageof 40
Sort By:
Addiction (Abingdon, England)|November 3, 2021
Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, AustraliaAntoine Chaillon, Chrianna Bharat, Jack Stone, et al.
AIDS (London, England)|August 8, 2013
Can the UNAIDS modes of transmission model be improved? A comparison of the original and revised model projections using data from a setting in west AfricaHolly J Prudden, Charlotte H Watts, Peter Vickerman, et al.
The Lancet. Infectious Diseases|November 23, 2019
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological dataKatharine J Looker, Nicky J Welton, Keith M Sabin, et al.
AIDS (London, England)|September 21, 2010
To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysisPeter Vickerman, Anna M Foss, Michael Pickles, et al.
Interactive Journal of Medical Research|August 23, 2022
Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness AnalysisGeoff McCombe, Davina Swan, John S Lambert, et al.
Journal of the Royal Society, Interface|August 31, 2018
A mechanistic hydro-epidemiological model of liver fluke riskLudovica Beltrame, Toby Dunne, Hannah Rose Vineer, et al.
The International Journal on Drug Policy|January 29, 2026
Gender differences in social networks of women and men who inject drugs in KenyaHannah N Manley, Lindsey R Riback, Mercy Nyakowa, et al.
The Journal of Infectious Diseases|July 24, 2023
Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling AnalysisAdelina Artenie, Jack Stone, Shelley N Facente, et al.
The International Journal on Drug Policy|April 3, 2026
Gender differences in hepatitis C virus incidence in and out of opioid agonist treatment among people who inject drugs in Montréal, Canada, March 2011-March 2024Milca Meconnen, Bluma Blake Kleiner, Adelina Artenie, et al.
The Lancet. Global Health|October 12, 2014
Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south IndiaAnna Vassall, Michael Pickles, Sudhashree Chandrashekar, et al.
Pageof 40

Showing results (191-200 of 397) with videos related to

Sort By:
Pageof 40
Addiction (Abingdon, England)|November 3, 2021
Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, AustraliaAntoine Chaillon, Chrianna Bharat, Jack Stone, et al.
AIDS (London, England)|August 8, 2013
Can the UNAIDS modes of transmission model be improved? A comparison of the original and revised model projections using data from a setting in west AfricaHolly J Prudden, Charlotte H Watts, Peter Vickerman, et al.
The Lancet. Infectious Diseases|November 23, 2019
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological dataKatharine J Looker, Nicky J Welton, Keith M Sabin, et al.
AIDS (London, England)|September 21, 2010
To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysisPeter Vickerman, Anna M Foss, Michael Pickles, et al.
Interactive Journal of Medical Research|August 23, 2022
Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness AnalysisGeoff McCombe, Davina Swan, John S Lambert, et al.
Journal of the Royal Society, Interface|August 31, 2018
A mechanistic hydro-epidemiological model of liver fluke riskLudovica Beltrame, Toby Dunne, Hannah Rose Vineer, et al.
The International Journal on Drug Policy|January 29, 2026
Gender differences in social networks of women and men who inject drugs in KenyaHannah N Manley, Lindsey R Riback, Mercy Nyakowa, et al.
The Journal of Infectious Diseases|July 24, 2023
Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling AnalysisAdelina Artenie, Jack Stone, Shelley N Facente, et al.
The International Journal on Drug Policy|April 3, 2026
Gender differences in hepatitis C virus incidence in and out of opioid agonist treatment among people who inject drugs in Montréal, Canada, March 2011-March 2024Milca Meconnen, Bluma Blake Kleiner, Adelina Artenie, et al.
The Lancet. Global Health|October 12, 2014
Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south IndiaAnna Vassall, Michael Pickles, Sudhashree Chandrashekar, et al.
Pageof 40